Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(186)
•••
Comment by robertshawon Aug 17, 2017 12:01pm
91 Views
Post# 26592076

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Heavy asks are disappearing...

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Heavy asks are disappearing...
robertshaw wrote:
2b7f6fab wrote: TLT has cured 3 people, maybe 4 or 9. what more could you ask for?
bionicjoe wrote:
HC is protecting the general public. Isn't it obvious?

They will only allow the commercialization of a new medical procedure if it is proven to be safe, effective and repeatable To do that it will take years not months to satisfy HC and FDA protocols. It can't be any other way if you want a new standard of care that cancer doctors will trust to recommend to their patients.




Not much, miserable basement boy just needs his pharking boss' regular paycheck and some decent bonus based on his 247's bashing duty. They don't pharking care about cancer patients cure or not, basement just keeps bashing, and the pharking basement boss just keeps manipulating,


I guess basementboy and his pharking boss have a many years' contract not months as he just indicated in his above post.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities